Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Net Margin (QoQ) (2018 - 2026)

Analysis

Verastem (VSTM) Net Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,905.00
Mar 31, 2026 -25,383.00
Dec 31, 2025 37,276.00
Sep 30, 2025 85,908.00
Mar 31, 2022 236,957.00
Dec 31, 2021 113.63 Mn
Sep 30, 2021 -113.59 Mn
Jun 30, 2021 -188,626.00
Mar 31, 2021 239,322.00
Dec 31, 2020 -390,406.00
Sep 30, 2020 55,095.00
Jun 30, 2020 21,714.00
Mar 31, 2020 30,289.00
Dec 31, 2019 -72,058.00
Sep 30, 2019 101,178.00
Jun 30, 2019 93,472.00
Mar 31, 2019 76,981.00
Dec 31, 2018 -291,028.00
Sep 30, 2018 4,395.00